Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kuyucak

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
The Journal of Biological Chemistry|May 9, 2014
Na+ interactions with the neutral amino acid transporter ASCT1Amanda J Scopelliti, Germano Heinzelmann, Serdar Kuyucak, et al.
Plos One|March 20, 2012
Position of the third Na+ site in the aspartate transporter GltPh and the human glutamate transporter, EAAT1Turgut Bastug, Germano Heinzelmann, Serdar Kuyucak, et al.
Biophysical Journal|March 28, 2002
Reservoir boundaries in Brownian dynamics simulations of ion channelsBen Corry, Matthew Hoyles, Toby W Allen, et al.
FEBS Letters|October 16, 2012
A C-terminally amidated analogue of ShK is a potent and selective blocker of the voltage-gated potassium channel Kv1.3Michael W Pennington, M Harunur Rashid, Rajeev B Tajhya, et al.
Frontiers in Pediatrics|December 5, 2022
S945L-CFTR molecular dynamics, functional characterization and tezacaftor/ivacaftor efficacy <i>in vivo</i> and <i>in vitro</i> in matched pediatric patient-derived cell modelsKatelin M Allan, Miro A Astore, Laura K Fawcett, et al.
The Journal of Biological Chemistry|November 11, 2008
The pore domain outer helix contributes to both activation and inactivation of the HERG K+ channelPengchu Ju, Guilhem Pages, R Peter Riek, et al.
Plos One|November 19, 2013
A potent and selective peptide blocker of the Kv1.3 channel: prediction from free-energy simulations and experimental confirmationM Harunur Rashid, Germano Heinzelmann, Redwan Huq, et al.
Scientific Reports|March 29, 2014
A potent and Kv1.3-selective analogue of the scorpion toxin HsTX1 as a potential therapeutic for autoimmune diseasesM Harunur Rashid, Redwan Huq, Mark R Tanner, et al.
Frontiers in Molecular Biosciences|June 16, 2023
Q1291H-CFTR molecular dynamics simulations and <i>ex vivo</i> theratyping in nasal epithelial models and clinical response to elexacaftor/tezacaftor/ivacaftor in a Q1291H/F508del patientKatelin M Allan, Miro A Astore, Egi Kardia, et al.
Iscience|January 24, 2022
Molecular dynamics and functional characterization of I37R-CFTR lasso mutation provide insights into channel gating activitySharon L Wong, Nikhil T Awatade, Miro A Astore, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
The Journal of Biological Chemistry|May 9, 2014
Na+ interactions with the neutral amino acid transporter ASCT1Amanda J Scopelliti, Germano Heinzelmann, Serdar Kuyucak, et al.
Plos One|March 20, 2012
Position of the third Na+ site in the aspartate transporter GltPh and the human glutamate transporter, EAAT1Turgut Bastug, Germano Heinzelmann, Serdar Kuyucak, et al.
Biophysical Journal|March 28, 2002
Reservoir boundaries in Brownian dynamics simulations of ion channelsBen Corry, Matthew Hoyles, Toby W Allen, et al.
FEBS Letters|October 16, 2012
A C-terminally amidated analogue of ShK is a potent and selective blocker of the voltage-gated potassium channel Kv1.3Michael W Pennington, M Harunur Rashid, Rajeev B Tajhya, et al.
Frontiers in Pediatrics|December 5, 2022
S945L-CFTR molecular dynamics, functional characterization and tezacaftor/ivacaftor efficacy <i>in vivo</i> and <i>in vitro</i> in matched pediatric patient-derived cell modelsKatelin M Allan, Miro A Astore, Laura K Fawcett, et al.
The Journal of Biological Chemistry|November 11, 2008
The pore domain outer helix contributes to both activation and inactivation of the HERG K+ channelPengchu Ju, Guilhem Pages, R Peter Riek, et al.
Plos One|November 19, 2013
A potent and selective peptide blocker of the Kv1.3 channel: prediction from free-energy simulations and experimental confirmationM Harunur Rashid, Germano Heinzelmann, Redwan Huq, et al.
Scientific Reports|March 29, 2014
A potent and Kv1.3-selective analogue of the scorpion toxin HsTX1 as a potential therapeutic for autoimmune diseasesM Harunur Rashid, Redwan Huq, Mark R Tanner, et al.
Frontiers in Molecular Biosciences|June 16, 2023
Q1291H-CFTR molecular dynamics simulations and <i>ex vivo</i> theratyping in nasal epithelial models and clinical response to elexacaftor/tezacaftor/ivacaftor in a Q1291H/F508del patientKatelin M Allan, Miro A Astore, Egi Kardia, et al.
Iscience|January 24, 2022
Molecular dynamics and functional characterization of I37R-CFTR lasso mutation provide insights into channel gating activitySharon L Wong, Nikhil T Awatade, Miro A Astore, et al.
Pageof 12